ANKS1B Interacts with the cerebral cavernous malformation protein-1 and controls endothelial permeability but not sprouting angiogenesis

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Herberich, Stefanie E ^a,b   Klose, Ralph ^a   Moll, Iris ^a   Yang, Wan Jen ^a   Wüstehube Lausch, Joycelyn ^a,b,d   Fischer, Andreas ^a,b,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d BIONTECH AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANKS1A PROTEIN; ANKS1B PROTEIN; BINDING PROTEIN; CEREBRAL CAVERNOUS MALFORMATION PROTEIN 1; KRIT1 PROTEIN; RHO KINASE; UNCLASSIFIED DRUG; ANKS1B PROTEIN, HUMAN; CARRIER PROTEIN; KRIT1 PROTEIN, HUMAN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN;

ANGIOGENESIS; ARTICLE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SCREENING TEST; CELL ADHESION; CELL CULTURE; CELL MOTION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

BLOTTING, WESTERN; CARRIER PROTEINS; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84956908217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145304     Document Type: Article

References (36)

1. Fischer A, Zalvide J, Faurobert E, Albiges-Rizo C, Tournier-Lasserve E (2013) Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med 19: 302-308. doi:10.1016/j.molmed.2013.02.004 PMID: 23506982.
2. Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D (2009) Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol 5: 659-670. doi:10.1038/nrneurol.2009.177 PMID: 19953116.
3. Labauge P, Denier C, Bergametti F, Tournier-Lasserve E (2007) Genetics of cavernous angiomas. Lancet Neurol 6: 237-244. PMID: 17303530.
4. Glading AJ, Ginsberg MH (2010) Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling. Dis Model Mech 3: 73-83. doi:10.1242/dmm.003293 PMID: 20007487.
5. Boulday G, Blecon A, Petit N, Chareyre F, Garcia LA, Niwa-Kawakita M, et al. (2009) Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis Model Mech 2: 168-177. doi:10.1242/dmm.001263 PMID: 19259391.
6. Pagenstecher A, Stahl S, Sure U, Felbor U (2009) A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 18: 911-918. doi:10.1093/hmg/ddn420 PMID: 19088124.
7. Zheng X, Xu C, Di Lorenzo A, Kleaveland B, Zou Z, Seiler C, et al. (2010) CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J Clin Invest 120: 2795-2804. doi:10.1172/JCI39679 PMID: 20592472.
8. Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, et al. (2011) Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest 121: 1871-1881. doi:10.1172/JCI44393 PMID: 21490399.
9. Stockton RA, Shenkar R, Awad IA, Ginsberg MH (2010) Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207: 881-896. doi:10.1084/jem.20091258 PMID: 20308363.
10. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al. (2009) The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15: 177-184. doi:10.1038/nm.1911PMID: 19151728.
11. Wustehube J, Bartol A, Liebler SS, Brutsch R, Zhu Y, Felbor U, et al. (2010) Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A 107: 12640-12645. doi:10.1073/pnas.1000132107 PMID: 20616044.
12. Kim J, Lee H, Kim Y, Yoo S, Park E, Park S (2010) The SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptors. Mol Cell Biol 30: 1582-1592. doi:10.1128/MCB.01605-09 PMID: 20100865.
13. Brutsch R, Liebler SS, Wustehube J, Bartol A, Herberich SE, Adam MG, et al. (2010) Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis. Circ Res 107: 592-601. doi:10.1161/CIRCRESAHA.110.217257 PMID: 20616313.
14. Cunningham K, Uchida Y, O'Donnell E, Claudio E, Li W, Soneji K, et al. (2011) Conditional deletion of Ccm2 causes hemorrhage in the adult brain: A mouse model of human cerebral cavernous malformations. Hum Mol Genet 20: 3198-3206. doi:10.1093/hmg/ddr225 PMID: 21596842.
15. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC (2001) Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10: 2953-2960. PMID: 11741838.
16. Hilder TL, Malone MH, Bencharit S, Colicelli J, Haystead TA, Johnson GL, et al. (2007) Proteomic identification of the cerebral cavernous malformation signaling complex. J Proteome Res 6: 4343-4355. PMID: 17900104.
17. Faurobert E, Rome C, Lisowska J, Manet-Dupe S, Boulday G, Malbouyres M, et al. (2013) CCM1- ICAP-1 complex controls beta1 integrin-dependent endothelial contractility and fibronectin remodeling. J Cell Biol 202: 545-561. doi:10.1083/jcb.201303044PMID: 23918940.
18. Liu W, Draheim KM, Zhang R, Calderwood DA, Boggon TJ (2013) Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation. Mol Cell 49: 719-729. doi:10.1016/j.molcel.2012.12.005 PMID: 23317506.
19. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498: 492-496. doi:10.1038/nature12207 PMID: 23748444.
20. Borikova AL, Dibble CF, Sciaky N, Welch CM, Abell AN, Bencharit S, et al. (2010) Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem 285: 11760- 11764. doi:10.1074/jbc.C109.097220 PMID: 20181950.
21. Fu X, McGrath S, Pasillas M, Nakazawa S, Kamps MP (1999) EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1. Oncogene 18: 4920-4929. PMID: 10490826.
22. He Y, Zhang H, Yu L, Gunel M, Boggon TJ, Chen H, et al. (2010) Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci Signal 3: ra26. doi:10.1126/scisignal.2000722 PMID: 20371769.
23. Faurobert E, Albiges-Rizo C (2010) Recent insights into cerebral cavernous malformations: A complex jigsaw puzzle under construction. FEBS J 277: 1084-1096. doi:10.1111/j.1742-4658.2009.07537.x PMID: 20096036.
24. Zhong J, Chaerkady R, Kandasamy K, Gucek M, Cole RN, Pandey A (2011) The interactome of a PTB domain-containing adapter protein, Odin, revealed by SILAC. J Proteomics 74: 294-303. doi:10.1016/j.jprot.2010.11.006 PMID: 21081186.
25. Kristiansen TZ, Nielsen MM, Blagoev B, Pandey A, Mann M (2004) Mouse embryonic fibroblasts derived from Odin deficient mice display a hyperproliiferative phenotype. DNA Res 11: 285-292. PMID: 15500253.
26. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, et al. (2005) High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307: 1621-1625. PMID: 15761153.
27. Jordan BA, Fernholz BD, Khatri L, Ziff EB (2007) Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers and protein synthesis in neurons. Nat Neurosci 10: 427-435. PMID: 17334360.
28. Pandey A, Blagoev B, Kratchmarova I, Fernandez M, Nielsen M, Kristiansen TZ, et al. (2002) Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases. Oncogene 21: 8029-8036. PMID: 12439753.
29. Fisher OS, Liu W, Zhang R, Stiegler AL, Ghedia S, Weber JL, et al. (2015) Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations. J Biol Chem 290: 2842-2853. doi:10.1074/jbc.M114.616433 PMID: 25525273.
30. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, et al. (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4: 901-906. PMID: 12402047.
31. Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA (2002) KRIT1 association with the integrin-binding protein ICAP-1: A new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11: 389-396. PMID: 11854171.
32. Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, et al. (2005) CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14: 2521-2531. PMID: 16037064.
33. Zhang J, Rigamonti D, Dietz HC, Clatterbuck RE (2007) Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations. Neurosurgery 60: 353-359; discussion 359. PMID: 17290187.
34. Gunel M, Laurans MS, Shin D, DiLuna ML, Voorhees J, Choate K, et al. (2002) KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci U S A 99: 10677-10682. PMID: 12140362.
35. Liu JJ, Stockton RA, Gingras AR, Ablooglu AJ, Han J, Bobkov AA, et al. (2011) A mechanism of Rap1- induced stabilization of endothelial cell-cell junctions. Mol Biol Cell 22: 2509-2519. doi:10.1091/mbc.E11-02-0157 PMID: 21633110.
36. Glading A, Han J, Stockton RA, Ginsberg MH (2007) KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 179: 247-254. PMID: 17954608.